Achaogen, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
Key FDA Events In June Investors Need To Watch Out For
Article By: Zacks Investment Research
Sunday, June 3, 2018 12:49 PM EDT
It has been a busy year for the FDA so far with the agency approving 14 drugs. The approval of these drugs should boost their respective companies’ top line as a few of them are struggling with decline in sales of legacy drugs.
In this article: MRK, VRX, ARRY, GWPH, ALKS, AKAO
Read
5 Drug Stocks Poised To Beat Earnings Estimates In Q4
Article By: Arpita Dutt
Thursday, February 9, 2017 11:11 AM EDT
A positive earnings picture continues to emerge from the fourth-quarter earnings season with both earnings and revenue growth improving compared to recent quarters.
In this article: EXEL, INCY, JAZZ, IRWD, AKAO
Read
4 Biotech Stocks That More Than Doubled In 2016
Article By: Arpita Dutt
Thursday, December 22, 2016 11:47 AM EDT
2016 has not been a great year for biotech stocks, which were under intense pressure with issues like increasing political and media focus on high price tags for drugs, and the changing competitive scenario weighing on the sector.
In this article: CLCD, EXEL, TSRO, AKAO
Read
The FDA: Small-Cap Catalyst Or Small-Cap Killer?
Article By: Paradigm Press
Friday, December 16, 2016 9:37 AM EDT
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.
In this article: BMY, LLY, MRK, PFE, AMGN, CORT, VYGR, SRPT, VCEL, AKAO, CERC, PRTO, OPHT
Read
Twas The Night Before The Fed
Article By: Joshua Hayes
Tuesday, December 13, 2016 10:30 PM EDT
Stocks run higher as traders await the Fed’s decision on interest rates. A solid move today by stocks led by the Nasdaq as traders rush into technology stocks.
In this article: IWM, SPX, AKAO
Read
All Posts

Latest Tweets for $AKAO

No tweets yet!

PARTNER HEADLINES